Aveanna Healthcare (NASDAQ:AVAH) Insider Patrick Cunningham Sells 125,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 125,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the transaction, the insider directly owned 212,755 shares in the company, valued at $1,614,810.45. This trade represents a 37.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aveanna Healthcare Stock Down 0.1%

NASDAQ AVAH opened at $7.67 on Friday. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The business’s fifty day simple moving average is $6.75 and its 200-day simple moving average is $7.86. The firm has a market cap of $1.67 billion, a PE ratio of 6.50, a P/E/G ratio of 0.91 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.13 by $0.05. The business had revenue of $647.92 million for the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company’s quarterly revenue was up 15.9% on a year-over-year basis. As a group, equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.56 earnings per share for the current year.

Institutional Trading of Aveanna Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the business. Caitong International Asset Management Co. Ltd increased its stake in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares during the period. Summit Securities Group LLC purchased a new stake in shares of Aveanna Healthcare during the first quarter worth $53,000. Quantbot Technologies LP purchased a new stake in shares of Aveanna Healthcare during the second quarter worth $43,000. Lion Street Advisors LLC purchased a new stake in shares of Aveanna Healthcare during the third quarter worth $89,000. Finally, EverSource Wealth Advisors LLC increased its position in shares of Aveanna Healthcare by 88,100.0% during the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock worth $102,000 after acquiring an additional 11,453 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. BMO Capital Markets reduced their price objective on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 20th. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Truist Financial boosted their target price on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research report on Wednesday. Royal Bank Of Canada boosted their target price on Aveanna Healthcare from $9.00 to $10.00 and gave the company a “sector perform” rating in a research report on Friday, May 15th. Finally, Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Aveanna Healthcare presently has an average rating of “Moderate Buy” and an average target price of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.